Our Parkinson's Place: BioCrossroads Release: Indiana Life Sciences Start-Up Garners More Than $2 Million To Design, Build Telehealth Platform For Parkinson's Patients

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

Wednesday, May 18, 2016

BioCrossroads Release: Indiana Life Sciences Start-Up Garners More Than $2 Million To Design, Build Telehealth Platform For Parkinson's Patients

INDIANAPOLIS, May 18, 2016

SpeechVive

More than 8 million people worldwide and 1.5 million in the United States suffer from chronic neurological diseases, such as Parkinson's disease. Along with the physical symptoms associated with Parkinson's disease, patients can also suffer from a speech condition known as hypokinetic dysarthria. The condition is characterized by reduced vocal volume, impaired speech rate and diminished articulation.

SpeechVive is an Indiana start-up company, based on the research of Jessica Huber, Ph.D. at the Department of Speech, Language, and Hearing Sciences, Purdue University, focused on developing medical devices to improve speech clarity of Parkinson's patients. The SpeechVive device, which fits like a hearing aid in the patient's ear, detects when a patient is speaking and elicits louder and clearer speech through an involuntary reflex known as the Lombard Effect.

SpeechVive was awarded a two-year $1.3 million grant from the National Institutes of Health (NIH) as well as an additional $975,000 in investments from BioCrossroads' Indiana Seed Fund II, The Purdue Foundry and a private investor. The funds will be used to design, build and test a telehealth platform that enables speech pathologists to program the SpeechVive device from a remote location anywhere in the world. The telehealth platform will allow SpeechVive to expand more rapidly by reaching elderly or physically impaired patients who cannot travel to speech pathologists.

"Approximately 89 percent of people with Parkinson's disease will have speech issues which SpeechVive can address. A telehealth platform will help us rapidly expand into more rural areas within the U.S. and to areas outside the U.S. where there are larger populations impacted by Parkinson's disease," Dr. Huber added. "This funding will be transformative for our company."

Dr. Huber has worked with Parkinson's patients at Purdue for the past 15 years.

"SpeechVive is an excellent example of how research and discovery in the lab of one of our universities can be translated into a commercialized product that improves the quality of life for patients throughout the world," said David L. Johnson, President and CEO of BioCrossroads. "The company has promising technology that is attracting investors both inside the state and nationally."

To learn more about SpeechVive, visit speechvive.com

About BioCrossroads

BioCrossroads (www.biocrossroads.com) is Indiana's initiative to grow, advance and invest in the life sciences, a public-private collaboration that supports the region's existing research and corporate strengths while encouraging new business development. BioCrossroads provides money and support to life sciences businesses, launches new life sciences enterprises (Indiana Biosciences Research Institute, Indiana Health Information Exchange, BioCrossroadsLINX, OrthoWorx and Datalys Center), expands collaboration and partnerships among Indiana's life science institutions, promotes science education and markets Indiana's life sciences industry.